Showing results (31-40 of 773) with videos related to
Sort By:
Pageof 78
Pharmacoeconomics|January 22, 2005
The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovationJerry AvornAmerican Journal of Epidemiology|October 10, 2024
Invited commentary on interventional pharmacoepidemiology: origins, current status, and future possibilitiesJerry AvornHealth Affairs (Project Hope)|October 7, 2003
Advertising and prescription drugs: promotion, education, and the public's healthJerry AvornPharmacoeconomics|November 30, 2002
Balancing the cost and value of medications: the dilemma facing cliniciansJerry AvornArthritis and Rheumatism|December 1, 2006
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritisDaniel H Solomon, Jerry Avorn, Jeffrey N Katz, et al.The Journal of Rheumatology|April 1, 2005
Older adults' knowledge and beliefs about osteoporosis: results of semistructured interviews used for the development of educational materialsMichele Burgener, Marilyn Arnold, Jeffrey N Katz, et al.American Heart Journal|July 29, 2008
Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritisSoko Setoguchi, Sebastian Schneeweiss, Jerry Avorn, et al.Contemporary Clinical Trials|April 20, 2005
Osteoporosis action: design of the healthy bones project trialDaniel H Solomon, M Alan Brookhart, Jennifer Polinski, et al.Mayo Clinic Proceedings|February 12, 2005
Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventionsDaniel H Solomon, Charles Morris, Hailu Cheng, et al.The New England Journal of Medicine|December 2, 2005
Risk of death in elderly users of conventional vs. atypical antipsychotic medicationsPhilip S Wang, Sebastian Schneeweiss, Jerry Avorn, et al.Pageof 78